Recent data suggest that a-toxin, the major hemolysin of Staphylococcus aureus, induces cell death via the classical apoptotic pathway. Here we demonstrate, however, that although zVAD-fmk or overexpression of Bcl-2 completely abrogated caspase activation and internucleosomal DNA fragmentation, they did not significantly affect a-toxin-induced death of Jurkat T or MCF-7 breast carcinoma cells. Caspase inhibition had also no effect on a-toxin-induced lactate dehydrogenase release and ATP depletion. Furthermore, whereas early assessment of apoptosis induction by CD95 resulted solely in the generation of cells positive for active caspases that were, however, not yet permeable for propidium iodide, a substantial proportion of a-toxin-treated cells were positive for both active caspases and PI. Finally, electron microscopy demonstrated that even in the presence of active caspases, a-toxin-treated cells displayed a necrotic morphology characterized by cell swelling and cytoplasmic vacuolation. Together, our data suggest that a-toxin-induced cell death proceeds even in the presence of activated caspases, at least partially, in a caspase-independent, necrotic-like manner.
Introduction
Cells can die in two fundamental ways: by a yet ill-defined necrotic pathway following damage of their cell membrane or by a well-characterized process, called programmed cell death or apoptosis that includes the shrinkage and blebbing of the intact cell membrane. 1 Necrotic cell death results from physical or chemical injury, and is accompanied by swelling of the cells and organelles, as well as by cytoplasmic vacuolation and increased permeability of the plasma membrane allowing the passive diffusion of ions. Apoptosis, on the other hand, is characterized by stereotypic biochemical and morphological changes including chromatin condensation, oligonucleosomal DNA fragmentation and formation of apoptotic bodies that can be cleared by phagocytes without producing an inflammatory response. 1 Most of these alterations are due to the activation of a class of intracellular cysteine proteases, called caspases that cleave cellular substrates after aspartate residues. 2, 3 Apoptosis can be achieved by a variety of stimuli such as death receptors, DNA-damaging agents, cytokine withdrawal, etc., all of which efficiently activate caspases. As cell death can be blocked in many apoptotic, but not necrotic systems by caspase inhibitors, it was widely accepted that these proteases are indispensable for apoptosis, and hence activation of caspases classified a particular mode of cell death as apoptosis. However, recent reports suggest the existence of intermediate cell death forms, making it sometimes difficult to unambiguously define the mode of death a particular cell is undergoing. 1, 4 Perhaps, two of the first clear demonstrations of caspase-independent programmed cell death were apoptosis induced by the proapoptotic Bcl-2 homologues Bax 5, 6 and Bak. 7 Although cell death mediated by both molecules was accompanied by caspase activation, the inhibition of these enzymes only blocked the apoptotic morphology, but not cell death itself. More recent examples include apoptosis induced during thymocyte development, 8 HIV-1 infection of primary T cells, 9 stimulation of surface antigens such as CD4, CD47 and CD99, [10] [11] [12] or CTLmediated target cell lysis. 13 In parallel, it became evident that apoptosis can also occur in the complete absence of caspase activation. 14, 15 Even death receptors such as CD95 or TNF receptor-1, which were originally believed to mediate cell death exclusively via the direct activation of the caspase cascade, were shown to simultaneously activate mechanistically different death pathways leading either to necrosis or apoptosis. [16] [17] [18] [19] Thus, the presence or absence of active caspases alone does not qualify a particular cell death system as apoptosis or necrosis, respectively. In most of the abovementioned systems, however, cell death could be blocked by the antiapoptotic protein Bcl-2, thereby clearly distinguishing these systems from necrosis in which cell death is merely a result of the damage per se. Therefore, the term apoptosislike programmed cell death 1 appears to be appropriate for death events that are under tight regulation of intracellular survival mechanisms.
Staphylococcus aureus is one of the most common grampositive bacterial pathogens that plays an increasing role in nosocomial infections such as abscess formation, osteomyelitis, endocarditis or pneumonia, which often require a prolonged and aggressive antibiotic treatment. 20 Among the most serious complications of S. aureus infections are manifestations of septic and toxic shock syndromes that may lead to multiple organ failure. 21 As tissue injury and a depletion of immune cells are characteristic features of septic and toxic shock syndromes, several studies have focused on cell death induction following exposure to microbial pathogens. 22, 23 Indeed, it was shown that S. aureus is able to induce apoptosis in various cell types including epithelial cells, endothelial cells, keratinocytes, osteoblasts as well as lymphocytes and macrophages. [24] [25] [26] [27] [28] [29] One of the key virulence determinants of S. aureus is a-toxin, a pore-forming protein of 34 kDa. At low doses, the toxin was shown to bind to specific, as yet unidentified cell surface receptors, and to produce small heptameric pores that selectively facilitate the release of monovalent ions, resulting in DNA fragmentation and apoptosis. 24, 30, 31 At high doses (46 mg/ml), in contrast, a-toxin nonspecifically adsorbs to the lipid bilayer, forming larger pores that are Ca 2 þ -permissive, which results in massive necrosis. In addition, we have recently demonstrated that only low a-toxin doses activate caspases, and that this activation is mediated via the intrinsic pathway independently of death receptors. 32 Thus, it appears that the mode of cell death critically depends on the concentration of a-toxin.
However, as discussed above, both oligonucleosomal DNA fragmentation and caspase activation are not necessarily required for apoptotic processes. Therefore, we analyzed this system in more detail, resulting in some intriguing findings that challenge the current concept of cell death induced by a-toxin. Using various methods for cell death assessment, we found that inhibition of caspases did not protect cells from a-toxininduced death. Moreover, and most interestingly, our results suggest that even in the presence of active caspases a-toxin induces cell death via a necrotic pathway. Thus, our findings are in sharp contrast to numerous death models in which the caspase-independent mode of cell death only surfaces when the activation of caspases is inhibited, and therefore indicate that inhibition of caspases might not be sufficient to prevent the demise of S. aureus-infected cells.
Results
Caspase inhibition by zVAD-fmk only partially prevents S. aureus a-toxin-induced DNA fragmentation Recently, we demonstrated that a-toxin, a major hemolysin of S. aureus, induces caspase activation via the mitochondrial pathway independently of death receptor signaling. 32 During this work, however, we also noticed that although S. aureusinduced caspase activation was almost completely blocked in Bcl-2-overexpressing Jurkat cells, the formation of hypodiploid nuclei as measured by FACS analysis could only be partially prevented in these cells. These results indicated that caspases might not be required for S. aureus-induced DNA fragmentation and cell death. To investigate this hypothesis in more detail, we first analyzed hypodiploid nuclei formation induced by either a-toxin or by a supernatant of the cytotoxic S. aureus strain Wood 46 in the absence or presence of the broad spectrum caspase inhibitor zVAD-fmk. Similar to the results obtained with Jurkat Bcl-2 cells, 32 caspase inhibition by zVAD-fmk resulted in only a partial decrease of S. aureusinduced DNA fragmentation (Figure 1a) 32 ), zVAD-fmk reduced hypodiploid nuclei formation by only 22 and 40%, respectively. In contrast, CD95-induced DNA fragmentation in Jurkat cells was almost completely blocked in the presence of zVAD-fmk (Figure 1a) . Interestingly, although S. aureusinduced formation of hypodiploid nuclei was only partially inhibited by zVAD-fmk, internucleosomal DNA fragmentation in Jurkat cells treated with various concentrations of the S. aureus strain Wood 46 was completely abrogated in the presence of this caspase inhibitor (Figure 1b) . Thus, our results indicate that S. aureus a-toxin induces DNA fragmentation in a caspase-dependent and -independent manner.
Caspase inhibition by zVAD-fmk or overexpression of Bcl-2 does not prevent a-toxin-induced cell death
To verify these results in another experimental setting, we analyzed the effect of zVAD-fmk on a-toxin-induced caspase-3 activation, the caspase responsible for internucleosomal DNA fragmentation during apoptosis. 33 The neutralizing antia-toxin antibody was included as a control. 32 As expected, the addition of zVAD-fmk completely abolished a-toxin-and Wood 46-induced caspase-3 activation, as demonstrated by Western blot analysis (Figure 2a ) and by the fluorogenic substrate assay, respectively (Figure 2b and d) . Caspase-3 activation was also efficiently blocked by the anti-a-toxin antibody when low a-toxin (o0.1 mg/ml) or Wood 46 (o0.5%) concentrations were used, whereas higher a-toxin or Wood 46 doses resulted in a partial activation of caspase-3 ( Figure 2a, b and d) . Both zVAD-fmk and anti-a-toxin also prevented the activation of the initiator caspases 8 and 9 (data not shown). CD95-induced caspase-3 activation, in contrast, was only blocked by zVADfmk, but not by the anti-a-toxin antibody, demonstrating the specificity of this antibody (Figure 2a) .
Remarkably, although both zVAD-fmk and the anti-a-toxin antibody efficiently blocked a-toxin-and Wood 46-mediated caspase activation, cell death was dose-dependently inhibited only by the anti-a-toxin antibody but not by zVAD-fmk, as determined by the trypan blue exclusion assay (Figure 2c and e). It is noteworthy that zVAD-fmk also had no effect on the progression of cell death, even when low a-toxin or Wood 46 doses that are known to efficiently activate caspase-3 were used. Therefore, these results indicate that caspases are dispensable for S. aureus-mediated cell death.
Next, we compared cell death and DNA fragmentation in Jurkat and Jurkat Bcl-2 cells treated with a-toxin in the presence or absence of zVAD-fmk. Consistent with our previous results (Figure 1a) , we observed that a-toxin induced two different DNA fragmentation events in Jurkat cells, which could be easily distinguished based on the inhibitory potential of zVAD-fmk (Figure 3a) . The zVAD-fmk-inhibitable and therefore caspase-dependent DNA fragmentation was, however, only evident when low a-toxin concentrations ranging from 0.01 to 0.03 mg/ml were used. This is in agreement with our previous report that caspases are only activated when low a-toxin doses were used. 32 Treatment of Jurkat cells with higher a-toxin doses (40.03 mg/ml) additionally resulted in a caspase-independent DNA fragmentation that could not be blocked by zVAD-fmk (Figure 3a) . In Jurkat Bcl-2 cells, however, a-toxin induced only a caspase-independent DNA fragmentation ( Figure 3b) , which is consistent with our previous finding that a-toxin is unable to induce caspase activation in these cells. 32 In contrast to zVAD-fmk, the anti-atoxin antibody completely blocked both caspase-dependent and -independent DNA fragmentation, demonstrating that both processes were indeed mediated by a-toxin (Figure 3a and b). As a control, induction of apoptosis in Jurkat and Jurkat Bcl-2 cells by either anti-CD95 or the anti-cancer drug etoposide resulted exclusively in caspase-dependent DNA fragmentation, as it could be completely blocked by zVAD-fmk but not by the anti-a-toxin antibody (Figure 3a and b inlets) .
To analyze whether the caspase-dependent apoptotic pathway contributes to cell death induced by a-toxin, we employed an FACS-based method using propidium iodide (PI)-stained cells. This assay system allows determination of the total percentage of cell death, regardless of whether the cells died via an apoptotic or necrotic pathway. Using this method, we could demonstrate that zVAD-fmk had no effect on a-toxin-mediated killing of Jurkat and Jurkat Bcl-2 cells, whereas CD95-or etoposide-induced death were significantly blocked by this caspase inhibitory peptide (Figure 3c, d ). Even with a-toxin concentrations ranging from 0.01 to 0.1 mg/ml that efficiently induced caspase activation ( Figure 2a ) and hence were expected to mediate apoptosis, zVAD-fmk was not able to diminish Jurkat cell death. In contrast, anti-a-toxin completely blocked a-toxin-induced death of both cell lines, but had no effect on CD95-or etoposide-induced apoptosis (Figure 3c, d ). In addition, cell death assessment by the trypan blue exclusion assay confirmed these results and revealed no differences in the susceptibility of both Jurkat cell lines to the cytotoxic activity of S. aureus Wood 46 supernatant ( Figure 3e ). Together, these results demonstrate that although S. aureus a-toxin efficiently induces caspase activation, cell death induced by this pathogen proceeds most likely in a caspase-independent manner.
S. aureus a-toxin induces caspase-independent high molecular weight DNA fragmentation These results indicate that also during CD95-induced apoptosis, signals that lead to caspase-dependent andindependent DNA fragmentation are generated. In contrast, H 2 O 2 -induced DNA fragmentation appears to proceed solely via a caspase-independent pathway, as zVAD-fmk did not change the pattern of high molecular weight DNA breaks ( Figure 4a , compare lanes 16 and 17) .
In addition to a-toxin, S. aureus also secretes a nuclease. To investigate whether our a-toxin preparation or the cytotoxic supernatant of S. aureus cultures exhibit intrinsic DNA fragmentation activity, we analyzed DNA isolated from untreated Jurkat cells, which was incubated with various concentrations of a-toxin or Wood 46 supernatant by pulsed field and by conventional gel electrophoresis. As shown in Figure 4b , DNA was only excessively fragmented by DNase I, but remained fully intact even in the presence of high a-toxin or Wood 46 concentrations. Thus, we conclude that a-toxin-and Wood 46-induced DNA fragmentation is not mediated by a contaminating nuclease, but most likely by activation of an as yet unknown intracellular caspase-independent DNase. 
S. aureus a-toxin mediates cell death via a necrotic pathway
So far, all experiments performed point to a caspaseindependent cell death induced by a-toxin. To verify these results in other experimental settings, we also assessed cell death by alternative methods. First, we measured the release of lactate dehydrogenase (LDH), an event that appears to be more closely associated with necrosis than apoptosis. Consistent with this, we observed a dramatic increase of LDH activity in supernatants of Jurkat and Jurkat Bcl-2 cells incubated with H 2 O 2 , a typical inducer of necrosis, whereas treatment of the cells with the apoptotic inducer CD95 did not result in a significant release of this enzyme (Figure 5b, d) . In , or incubated for 2 h at 371C with the indicated concentrations of a-toxin or Wood 46 supernatant. As a control, DNA was incubated with DNaseI (400 U/ ml). High molecular weight and internucleosomal DNA fragmentation were determined by PFGE (top) and CAGE (bottom), respectively. The positions of the DNA molecular size markers are indicated on the right addition, the caspase inhibitor zVAD-fmk had only a marginal effect on LDH release induced by both death stimuli, implying that this assay might be suitable to distinguish necrotic from apoptotic forms of cell death. When Jurkat or Jurkat Bcl-2 cells were incubated with the indicated concentrations of a-toxin, a dose-dependent increase in LDH activity was observed in their supernatants (Figure 5a, c) . Interestingly, this effect was even more pronounced in Jurkat Bcl-2 cells, a cell line in which S. aureus fails to induce caspase activation. 32 More important, however, was our finding that a-toxin-induced LDH release from both cell lines was only blocked in the presence of the anti-a-toxin antibody, but not by zVAD-fmk. In agreement with our previous data (Figures 2 and 3) , zVAD-fmk also had no effect even when low, caspase-activating a-toxin concentrations were used, confirming that a-toxin induces a caspaseindependent mode of cell death.
Recently, the high-mobility group 1 (HMGB1) protein was identified as another specific marker to distinguish necrosis from apoptosis. 34 It was shown that HMGB1 is only released into the supernatant of necrotic cells, but barely in the supernatant of apoptotic cells due to its tight association with chromatin. In agreement with this report, we observed only a slight release of HMGB1 into the supernatant of Jurkat cells stimulated for 14 h with anti-CD95 that was completely abrogated by zVAD-fmk (Figure 5e ). In contrast, when the cells were treated with either 30 mg/ml or 1 mg/ml a-toxin, a substantial HMGB1 release could be detected, which was only marginally affected by the presence of zVAD-fmk (Figure 5e ), further supporting the above drawn conclusion.
Intracellular (d)ATP is a critical coactivator of caspases required for the formation of the apoptosome in the mitochondrial death pathway. 2 Hence, in caspase-dependent apoptosis systems, inhibition of caspase activation by either Bcl-2 or zVAD-fmk should maintain the intracellular ATP levels. Based on this assumption, we monitored the ATP content of anti-CD95-or H 2 O 2 -treated Jurkat cells, which are considered to be type II cells in which CD95-induced apoptosis is mediated also via the intrinsic death pathway. 35 Indeed, anti-CD95-induced ATP depletion in Jurkat cells was completely abrogated in the presence of either zVAD-fmk or Bcl-2, confirming our assumption (Figure 6c ). In contrast, both caspase inhibitors had no effect on H 2 O 2 -induced ATP depletion, clearly demonstrating the caspase-independent necrotic mode of cell death (Figure 6c) . Therefore, measurement of the intracellular ATP content in the presence of caspase inhibitors represents an efficient assay to distinguish whether a particular cell death system requires active caspases or not.
In Jurkat cells, a-toxin mediates caspase activation solely via the mitochondrial death pathway, independently of death receptor signaling. 32 In contrast to the caspase-dependent mode of cell death instigated by anti-CD95, a-toxin induced a dose-dependent ATP depletion in Jurkat cells that could only be blocked by anti-a-toxin, but not by zVAD-fmk or Bcl-2 (Figures 6a and b, respectively) . In addition, our data reveal that also in contrast to CD95, a-toxin induced the intracellular loss of ATP in Jurkat and in Jurkat Bcl-2 cells with a similar dose dependency. Thus, with regard to some biochemical criteria, our data demonstrate that cell death induced by a-toxin resembles rather the caspase-independent necrotic death induced by H 2 O 2 than that of the caspase-dependent CD95-mediated apoptotic pathway.
So far, a-toxin-induced cell death was only assessed in Jurkat cells and with methods based on the uptake or release of small molecules through the cellular membrane. As a-toxin is a pore-forming toxin, these measurements may not accurately reflect the nature of cell death induced by this staphylococcal toxin. Therefore, a-toxin-induced cell death was also assessed in MCF-7 and MCF-7/CASP-3 breast carcinoma cells 33 by the crystal violet assay that is based on the staining of adherent and hence viable cells. In agreement with our previous results, we found that although both cell lines were efficiently killed by TNF or a-toxin, zVAD-fmk rescued only TNF-treated cells, but had no effect on cell death induced by a-toxin (Figure 6d ). Owing to a 47 bp deletion in the casp-3 gene, MCF-7 cells completely lack caspase-3 protein, which is required for internucleosomal DNA fragmentation. 33 However, caspase-3-deficient MCF-7 cells were killed by atoxin to a similar extent as caspase-3-expressing MCF-7 cells, clearly demonstrating that a-toxin-induced death is not only independent of caspase-3, but also independent of the characteristic apoptotic events mediated by this protease. Therefore, our data indicate that a-toxin induces a caspaseindependent necrotic death pathway. a-toxin induces a necrotic form of cell death that is biochemically and morphologically distinct from apoptosis even in the presence of active caspases
Numerous studies have described caspase-independent apoptosis pathways that, however, only surface in the presence of zVAD-fmk. [5] [6] [7] [16] [17] [18] [19] Common to all these systems was the observation that zVAD-fmk did not prevent cell death, but changed the apoptotic morphology to a necrotic phenotype. Having clearly established that inhibition of caspases does not protect cells from a-toxin-mediated cytotoxicity, the question still remained whether the same scenario applies to cell death induced by a-toxin, or whether a-toxin induces necrosis even in the presence of active caspases. In an attempt to answer this question, we first compared the cell death patterns induced by low (30 ng/ml) and high (1 mg/ml) atoxin concentrations with the apoptotic mode of cell death induced by anti-CD95 using the conventional annexin V/PI double-staining technique. This method allows to follow the fate of dying cells that under typical apoptotic conditions first stain positive for annexin V (early apoptotic cells) and then become double positive for annexin V and PI (late apoptotic or secondary necrotic cells). Anti-CD95 induced equal proportions of single-and double-positive cells that could be completely blocked by zVAD-fmk (Figure 7) . Overexpression of Bcl-2, however, only partially prevented anti-CD95-induced cell death (double-positive cells), but not the generation of single-positive annexin V-stained cells, which is consistent with the death receptor-mediated pathway. On the other hand, treatment of Jurkat cells with the low, caspase-activating dose of a-toxin did not result in the generation of annexin V singlepositive cells, but predominantly in annexin V/PI doublerelative fluorescence intensity PI Figure 7 Comparison of a-toxin-and anti-CD95-induced cell death by annexin V and PI double staining. Following treatment of Jurkat cells with the indicated concentrations of anti-CD95 or a-toxin for 14 h, the cells were double stained with propidium iodide and the fluorescence-labeled annexin V-FITC. Cell death and caspase activation were assessed in parallel by flow cytometric analyses. One representative experiment of two performed in duplicates is shown positive cells, an event that was also observed at 4 h (data not shown). This cell population was, in contrast to anti-CD95, not substantially decreased in the presence of zVAD-fmk and only partially reduced by Bcl-2. As expected, both means of caspase inhibition had also no effect on cell death induced by the higher a-toxin dose of 1 mg/ml (Figure 7 ). Of note, however, is our observation that the high a-toxin dose of 1 mg/ml, which is not capable of activating caspases (Figure 2) does not only induce the uptake of PI, but also the binding of annexin V (double-positive cells). This suggests that annexin V staining might be unrelated to caspases in a-toxin-induced cell death. Together, these results provide further evidence that a-toxin-induced cell death differs greatly from the classical apoptotic pattern induced by anti-CD95. When similar experiments were performed with a-toxintreated Jurkat cells, the results differed greatly from those obtained following anti-CD95 treatment. Here, a 4 h treatment with a-toxin induced a dose-dependent increase of cells positive for active caspases, which was exactly paralleled by PI-stained cells (Figure 8a, upper right panel) . The difference to the profile obtained with active caspase-3 ( Figure 2 ) is most likely due to the fact that besides caspase-3, a-toxin induces also the activation of other caspases such as caspase-8, -9, 32 -6, and -7, which can be all detected by the FITC-VAD-fmk substrate. Nevertheless, this result is in sharp contrast to CD95-induced apoptosis, and indicates that a-toxin-treated cells die via necrosis, despite the presence of active caspases. This assumption was further supported when the data were plotted in a manner that allows to assess the heterogeneity within the a-toxin-treated cell population in more detail. In contrast to anti-CD95, a 4 h treatment with atoxin significantly increased the proportion of double-positive cells, whereas both single-positive cell populations even decreased after a slight initial rise (Figure 8b (Figures 2, 3, 7) , we conclude that caspases, although efficiently activated, are dispensible for a-toxin-induced cell death. More importantly, our data demonstrate that a-toxin at least partially mediates a necrotic form of cell death even in the presence of active caspases. To confirm these findings at the ultrastructural level, we finally analyzed a-toxin-and anti-CD95-treated Jurkat cells by electron microscopy. Anti-CD95-treated Jurkat cells showed the typical morphological characteristics of apoptotic cells such as shrinkage, chromatin condensation and fragmentation into apoptotic bodies (Figure 9a, e) . As expected, all these events were completely abrogated in the presence of zVADfmk (Figure 9b, f) . However, a completely different picture emerged when the cells were treated with 30 ng/ml a-toxin, a dose that induces not only caspase activation, but also the uptake of PI (Figures 2, 7, 8 ). Here we observed a swelling not only of the cytoplasm, but also of the nucleus and nuclear envelope (Figure 9c ). In addition, excessive cytoplasmic vacuolation was visible, resembling a necrotic morphology. Moreover, the chromatin of a-toxin-treated cells was only partially condensed, whereas the mitochondria appeared extremely electron dense. As expected, inhibition of caspases by zVAD-fmk did not prevent these events and, most importantly, these cells appeared with a similar morphology as those treated with a-toxin alone (Figure 9d) . The phenomenon that a-toxin-treated Jurkat cells displayed prominent necrotic features (swelling of the nucleus, vacuolization) in the presence or absence of active caspases was observed throughout the entire preparations (Figure 9g, h) . Thus, our data reveal that caspase activation does not necessarily lead to an apoptotic mode of cell death.
Discussion a-toxin, the major hemolysin of S. aureus, is a pore-forming protein, which was shown to evoke the typical apoptotic alterations such as oligonucleosomal DNA fragmentation and caspase activation in a variety of cell types. 24, 25, 32 Previously, we have demonstrated that a-toxin is a mediator of S. aureusinduced cell death, and that it activates caspases via the mitochondrial pathway. 32 Caspase activation and subsequent apoptotic alterations such as oligonucleosomal DNA fragmentation and substrate cleavage were, however, only observed with low (o300 ng/ml) a-toxin doses. These findings are consistent with the current concept of a-toxin-induced cell death that only low a-toxin doses induce apoptosis, whereas treatment with higher doses results in massive necrosis. 24, 30, 31 Therefore, it was postulated that the mode of cell death might critically depend on the concentration of a-toxin.
This view, however, is now being challenged by our present study, showing that low a-toxin concentrations also induce, at least partially, a necrotic form of cell death even in the presence of activated caspases. This could be readily demonstrated in various cell death assays including the microscopic assessment of trypan blue-stained cells or in FACS analyses based on the uptake of PI into dead cells. Although caspase activation and subsequent apoptotic alterations such as oligonucleosomal DNA fragmentation and substrate cleavage in a-toxin-treated Jurkat cells were completely blocked by the broad-spectrum caspase-inhibitory peptide zVAD-fmk or by overexpression of Bcl-2, they could not prevent final cell death. Similar results were obtained by measuring the release of LDH and HMGB1 in cell supernatants. Regardless of whether caspases were inhibited or not, LDH activity and HMGB1 protein were predominantly detected in supernatants of a-toxin-treated cells, but barely in supernatants of apoptotic CD95-treated cells. Although it was recently shown that LDH can be also released by late apoptotic cells, 34 together our data suggest that, at all concentrations tested, a-toxin induces a necrotic rather than an apoptotic form of cell death. Furthermore, in contrast to the CD95-induced ATP depletion that was clearly dependent on the activation of caspases, caspase inhibition had no effect on the loss of intracellular ATP levels observed in a-toxin-treated Jurkat cells. As ATP is required for most apoptotic Figure 2 . In (c), condensed mitochondria are marked by an arrow and vacuoles by a V (magnification, Â 2600) processes, 17, 36 the caspase-independent loss of ATP also explains the inability of high a-toxin doses (4300 ng/ml) to activate caspase-3. Interestingly, in all assays performed, we did not detect any significant differences in the dose-and time (data not shown)-dependent a-toxin-induced cell death rates in the presence or absence of zVAD-fmk or Bcl-2. These results clearly demonstrate that caspases are not required for a-toxin-induced cell death and, furthermore, suggest that cell death may proceed even in the presence of active caspases independently of them.
As all these measurements are based on either the release or uptake of molecules through the cellular membrane, one could argue that they might not be adequate assessments of cell death induced by a pore-forming toxin. However, in contrast to TNF, a-toxin-induced death of MCF-7 breast carcinoma cells could not be blocked by zVAD-fmk, as assessed by the crystal violet assay that is based on the staining of viable adherent cells independently of pore formation. Importantly, a-toxin induced similar cell death rates in caspase-3-deficient and -proficient MCF-7 cells, clearly demonstrating that even low a-toxin concentrations induce cell death in a caspase-3-independent manner.
Caspase-independent apoptosis was recently observed in a variety of in vitro systems, including that induced by Baxrelated proteins, [5] [6] [7] oncogenes and DNA-damaging agents, 7 and even death receptors. [16] [17] [18] [19] In addition, caspase-independent death pathways also appear to be involved in the negative selection of lymphocytes, 8, 37 and the embryonic removal of interdigital webs. 38 Caspase inhibition by zVADfmk efficiently blocked the typical apoptotic alterations in all of these systems, but could not prevent cell death itself. Instead, addition of zVAD-fmk changed the phenotype of the dying cell from the apoptotic into the necrotic morphology. As cell death, however, could be completely blocked by Bcl-2, and hence is under the tight control of an intrinsic survival program, they are considered as apoptosis-like programmed cell deaths.
1 This is in sharp contrast to cell death induced by a-toxin. Firstly, atoxin-induced cell death is not inhibitable by Bcl-2. Secondly, a-toxin concentrations up to 30 ng/ml induced an equal mixture of single caspase-and PI-positive cells as well as double-positive cells after 4 h, and the latter cell population was even further increased when higher a-toxin doses were applied. In contrast, CD95-induced apoptosis resulted after 4 h exclusively in the generation of single caspase-positive cells that were not yet permeable for PI, demonstrating that at least early apoptosis is solely characterized by caspase activation and not by membrane damage. However, it should be noted that FITC-VAD-fmk might also detect other proteases than caspases. Finally, and most importantly, ultrastructural analysis revealed that even Jurkat cells treated with low a-toxin doses (30 ng/ml) in the absence of caspase inhibitors displayed a prominent necrotic phenotype, characterized by swelling of the cytoplasm and nuclei as well as by cytoplasmic vacuolation. These intriguing observations demonstrate that a-toxin induces predominantly a necrotic form of cell death even in the presence of active caspases, which is unlike other caspase-independent apoptosis systems not under the control of an intrinsic survival program.
Why are caspases then activated so efficiently by S. aureus a-toxin? The answer might lie in the molecular properties of a-toxin itself. Insertion of a-toxin into the plasma membrane and subsequent pore formation will lead to K þ efflux and Na þ influx. 24, 30, 31 Potassium efflux has been described as an important event in the progression of apoptosis, 39 and prevention of this efflux was shown to inhibit death receptorand chemical-induced apoptosis. 40, 41 Potassium depletion may even be required for apoptosis, since normal intracellular K þ concentrations inhibited caspase activation and DNA fragmentation, 42 whereas the depletion of potassium ions with depolarizing drugs was shown to cause caspase activation. 43 Therefore, caspase activation by a-toxin might be only a side effect caused by the pore-forming properties of this molecule.
Treatment of Jurkat cells with a-toxin resulted in both oligonucleosomal and high molecular weight DNA fragmentation, and only the former event could be inhibited by zVADfmk. This is consistent with the caspase-3-dependent activation of ICAD/DFF45 that is necessary for the apoptosisspecific oligonucleosomal DNA fragmentation. 44, 45 As neither the a-toxin preparation nor supernatants of the cytotoxic S. aureus strain Wood 46 exhibited any intrinsic DNase activity, it is likely that a-toxin induces an as yet unknown factor that mediates high molecular weight DNA fragmentation. One possible candidate might be the recently identified apoptosisinducing factor (AIF). Upon treatment of cells with various stimuli, AIF was shown to be released from the mitochondria and to translocate to the nucleus, where it mediates via an as yet unknown factor high molecular weight DNA fragmentation. 46 Indeed, a similar scenario was described in cell death induced by S. pneumoniae which is also not inhibitable by zVAD-fmk. 47 In this study, exposure of microglia or neurons to live pneumococci caused the mitochondrial release of AIF and high molecular weight DNA fragmentation, which was blocked by microinjection of AIF-specific antiserum. As a-toxin can directly target mitochondria leading to cytochrome c release, 32 one might speculate that a-toxin-induced AIF translocation might be particularly important in those cell types, in which cell death induction may require internalization of S. aureus. [25] [26] [27] [28] In view of the fact that AIF does not exhibit intrinsic DNase activity, the downstream effectors remain obscure. Although several noncaspase proteases such as calpains, serine proteases and cathepsins have been implicated in cell death processes, [48] [49] [50] [51] and even the loading of any type of protease into cells provoked apoptosis-like morphologies, 52 it is presently unknown whether any of these proteases are involved in a-toxin-induced cell death. Nevertheless, the results presented here suggest that S. aureus a-toxin induces cell death independently of caspases. In addition, we provide strong evidence that this cell death proceeds via the necrotic pathway even in the presence of active caspases. On first glance, our previous report 32 and the present study appear to be contradictory. This is, however, not the case, as we demonstrate in both studies the efficient activation of caspases by a-toxin. Previously, we focused our investigations solely on the caspase activation pathway, but not on the mode of cell death induced by a-toxin. Therefore, the use of zVAD-fmk was not essential for these experiments. Having noticed, however, that the a-toxin-induced formation of hypodiploid nuclei was only partially inhibited in Jurkat-Bcl-2 cells, we performed additional studies using the pan caspase-inhibitory peptide zVAD-fmk, which enabled us to clearly demonstrate that caspases, although efficiently activated, are not essential for a-toxin-induced cell death. Hence, our findings deliver a cautionary note that even caspase activation might not always be linked to an apoptotic phenotype, and should help to better understand the pathophysiological function of S. aureus.
Materials and Methods

Cells, reagents and antibodies
All cell lines were maintained in RPMI 1640, supplemented with 10% fetal calf serum, 10 mM glutamine and antibiotics (all from Gibco BRL, Eggenstein, Germany). MCF-7 and MCF-7/CASP-3 breast carcinoma cells were described recently. 33 Jurkat cells stably transfected with Bcl-2 or empty vector alone were a gift from H Walczak (Heidelberg, Germany). The protease inhibitors aprotinin, antipain, pepstatin, leupeptin and phenylmethylsulfonyl fluoride (PMSF) as well as etoposide, RNase A, proteinase K and S. aureus a-toxin that showed a single band on a SDS polyacrylamide gel 32 were purchased from Sigma (Deisenhofen, Germany). The neutralizing polyclonal sheep anti-a-toxin antibody that was used at a 1 : 100 dilution was from Toxin Technology (Sarasota, FL, USA). The various death stimuli such as anti-CD95 mAb (BioCheck, Münster, Germany), H 2 O 2 and etoposide were always used at concentrations of 1 mg/ml, 200 mM and 100 mM, respectively. DNase I, which was used at a concentration of 400 U/ml was purchased from Roche Molecular Biochemicals (Mannheim, Germany). The fluorogenic caspase substrate DEVD-AMC (N-acetyl-Asp-Glu-Val-Asp-aminomethyl-coumarin) was from BIOMOL (Hamburg, Germany), FITC-VAD-fmk was from Promega and annexin V-FITC was purchased from BD Biosciences (Heidelberg, Germany). The caspase-inhibitory peptide zVAD-fmk that was always used at 50 mM was from Enzyme Systems (Dublin, CA, USA). The polyclonal goat antibodies recognizing the proform and the active subunits of caspase-3 were from R&D Systems (Minneapolis, USA) and the monoclonal HMGB1 antibody was from Pharmingen.
Bacterial strains, cultures and supernatants
Culture conditions and preparation of the supernatant of the S. aureus strain Wood 46 were described previously. 32 
Preparation of cell extracts and Western blotting
Cell extracts were prepared as described. 53 To confirm equal loading, protein concentrations were determined with the BioRad protein assay (BioRad, Munich, Germany). Proteins were separated in SDS-polyacrylamide gels, and subjected to Western blotting. The proteins were visualized by enhanced chemiluminescent staining using ECL reagents (Amersham, Freiburg, Germany).
Cell death assays
Cell death was assessed by various methods including microscopic examination of trypan blue-stained cells, in which a minimum of 100 cells, each on four different fields of a hemocytometer, was counted. Cell death was also determined by the uptake of PI (2 mg/ml; Sigma) in the absence or presence of annexin V-FITC into nonfixed cells, and subsequent flow cytometric analyses using the FSC/FL2 profile as described previously. 54 For each determination, a minimum of 10 000 cells was analysed. Lactate dehydrogenase (LDH) activity in supernatants of cells was assessed according to the protocol of the manufacturer (Roche Molecular Biochemicals). The standard crystal violet assay was employed as an alternative cell death measurement that is based on the staining of viable cells, and was performed as described. 53 Determination of intracellular ATP levels ATP levels were determined using the ATP Bioluminescence Assay Kit CLS II (Roche Molecular Biochemicals). Cells were collected by centrifugation at 41C and washed with PBS. The cell pellet was resuspended in 50 ml of ice-cold lysis buffer (100 mM Tris-HCl and 4 mM EDTA, pH 7.75), followed by the addition of 150 ml of boiling lysis buffer. The samples were incubated for 2 min at 991C. Cell lysates were centrifuged at 10 000 rpm for 1 min at 41C, and supernatants were collected. ATP measurement was performed using 50 ml of supernatant and 50 ml of luciferase reagent. The chemiluminescence was measured in a luminometer.
Determination of DNA fragmentation
The proportion of nuclei containing hypodiploid DNA was determined as previously described. 54 Briefly, apoptotic nuclei were prepared by lysing cells in a hypotonic lysis buffer (0.1% sodium citrate, 0.1% Triton X-100, 50 mg/ml propidium iodide), and subsequently analysed by flow cytometry on a FACScalibur (Becton Dickinson, Heidelberg, Germany) using CellQuest analysis software. For each determination, a minimum of 10 000 cells was analyzed. Internucleosomal DNA fragmentation was assessed using conventional agarose gel electrophoresis (CAGE). Cellular DNA was prepared by lysing 5 Â 10 6 Jurkat cells in 0.2 ml of 0.5 Â TE buffer (20 mM Tris, 0.5 mM EDTA, pH 8.0) containing 0.25% NP-40 and 50 mg RNase A at 371C for 30 min. Proteinase K (200 mg/sample) was added, and the samples were incubated for another 30 min at 371C. DNA sample buffer was added and aliquots were analyzed on 1.6% agarose gels. High molecular weight DNA fragmentation was determined by pulsed field gel electrophoresis (PFGE) as described. 55 Jurkat cells were resuspended in PBS, mixed with low melting agarose, cast into blocks and cut into slices. The slices were incubated in EC buffer (pH 7.5; 6 mM Tris-HCl, 1 M NaCl, 0.1 M EDTA, 0.5% Brij-58, 0.2% Na deoxycholate, 0.5% Na lauroyl sarcosine, 35 mg/ml RNase H) at 371C for 2 h, followed by TE buffer (10 mM Tris-HCl, 1 mM EDTA, 100 mg/ml proteinase K) at 501C overnight. Agarose slices of stimulated cells were loaded directly into the gel slots; those of unstimulated cells were incubated at 371C for 2 h with the respective agents, as detailed in the figure legends. Agarose gels (1%) were run in 0.5 Â TBE buffer (pH 8; 45 mM Tris, 45 mM boric acid, 1 mM EDTA) using a CHEF-DR II electrophoresis cell (BioRad) under the following conditions: 141C, 5-50 s switch time, 1201 angle and 6 V/cm.
Fluorimetric determination of caspase-3 activity and caspase staining Caspase-3 activity was measured using the fluorogenic DEVD-AMC substrate as previously described. 32 The catalytic activities are given in arbitrary units (AU). For double stainings of necrotic membrane damage and caspase activation, cells were incubated for 20 min at 371C with the pan-caspase in situ marker FITC-VAD-fmk in PBS at a final concentration of 10 mM, followed by staining with propidium iodide and subsequent flow cytometric analyses as described above.
Electron microscopy
Cells were fixed in 2.5% glutaraldehyde in 100 mM cacodylate buffer, pH 7.35, for 1 h at room temperature. After six washes of 15 min with 100 mM cacodylate buffer, the cells were incubated with 1% osmium tetroxide for 1 h at room temperature. The cells were then washed five times for 10 min in water before embedding, and all other procedures were essentially performed as described. 56 
